Amanote Research
Register
Sign In
Strategy to Address Innovative Off-Label Medication Use in China: Grading Management
European Journal of Clinical Pharmacology
- Germany
doi 10.1007/s00228-014-1729-3
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Pharmacology
Date
August 17, 2014
Authors
Hanbin Wu
Gao Wu
Publisher
Springer Science and Business Media LLC
Related search
Off-Label Medication Prescribing Patterns in Pediatrics: An Update
Hospital pediatrics
Medicine
Child Health
Pediatrics
Perinatology
«Off Label Use»: Nouvelles Recommandations
Bulletin des Médecins Suisses
Demographic and Neuropsychiatric Factors Associated With Off-Label Medication Use in Frontotemporal Dementia and Alzheimer’s Disease
Alzheimer Disease and Associated Disorders
Psychiatry
Clinical Psychology
Gerontology
Geriatrics
Mental Health
Off-Label Drug Use in Hospitalized Children
Archives of Pediatrics & Adolescent Medicine
Methylphenidate Off-Label Use and Safety
SpringerPlus
Multidisciplinary
Off-Label Use in Lymphoma Patients in Switzerland
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Off-Label Use of Approved Drugs
Nature Reviews Clinical Oncology
Oncology
Off-Label Use of Omalizumab in Pediatric Anaphylaxis
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Wheat Belt-Planting in China: An Innovative Strategy to Improve Production
Plant Production Science
Agronomy
Crop Science